Special L2M Guest this Week!

Diana Munteh is co-founding Sinon Biotech, a Berlin-based biotech startup spinning out of the Freie Universität Berlin. Sinon Biotech is developing a technology to improve the endosomal escape of gene therapeutics, making gene therapy more efficient. She has a medical background and business experience, leading Sinon Biotech with a passion for innovation and healthcare solutions. Diana is a graduate of Germany's first Nucleate Activator Program and, together with her co-founders, secured €300,000 in grants. She is currently completing her medical degree at Goethe University in Frankfurt am Main. Additionally, she is working on her medical doctoral thesis at the Institute of Medical Microbiology at Frankfurt University Hospital and serving as a remote student researcher at the Computational Neuroscience Outcomes Center at Brigham and Women's Hospital, Harvard Medical School.

FIRST COME, FIRST SERVE

Seating at all events is on a first come, first serve basis. RSVPs are encouraged so we have an accurate headcount for classroom size and catering purposes.

ACCESSIBILITY STATEMENT

The Harvard Grid welcomes attendees of all abilities to our events. If you would like to request accommodations or have questions about physical access, please contact grid@harvard.edu in advance of the event.

FUTURE COMMUNICATIONS

Please note: By registering, you agree to receive emails about this event and future communications from the Harvard Grid.